title: Clinical use of deslorelin (GnRH agonist) in companion animals: a review.
abstract: Over the years, many contraceptive medications have been developed for companion animals, but many secondary adverse effects have limited their use. A major advancement was achieved with the use of gonadotropin-releasing hormone (GnRH) analogues, mainly GnRH agonists, which mimic the effects of native GnRH. The development of effective low-dose, slow-release implants with potent agonists such as deslorelin (Suprelorin®, Virbac) have allowed their use to become widespread in recent years, with many potential benefits in companion animals. While the major application of deslorelin was initially male contraception, due to its two differing actions, either the stimulation of oestrus or the sterilization of fertility, its use has been increasing in the bitch as well. The aim of this study is to review the applications of deslorelin GnRH agonist implants in companion animal, such as dogs, cats and some exotic pets.
authors.affiliation: Department of Animal Medicine and Surgery, Veterinary Teaching Hospital, University of Murcia, Espinardo, Spain.
authors.forename: X
authors.initials: X
authors.lastname: Lucas
mesh_terms: D000818:Animals; D002415:Cats; D003270:Contraceptive Agents / Q000494:pharmacology*; D004285:Dogs; D004343:Drug Implants; D004971:Estrus / Q000187:drug effects; D005260:Female; D005298:Fertility / Q000187:drug effects; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists*; D008297:Male; D057805:Pets; D017329:Triptorelin Pamoate / Q000031:analogs & derivatives* / Q000494:pharmacology
chemical_list: D003270:Contraceptive Agents; D004343:Drug Implants; D017329:Triptorelin Pamoate; D007987:Gonadotropin-Releasing Hormone; C066438:deslorelin